News
Ipsen and its fellow French partner Genfit are competing with Intercept and Advanz’s Ocaliva, which was approved in 2016 and ...
5d
Barchart on MSNHere's What to Expect From Gilead Sciences’ Next Earnings ReportGilead Sciences, Inc. (GILD), based in Foster City, California, is a leading biopharmaceutical company focused on developing ...
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences ...
5d
Screen Rant on MSNHow The Handmaid's Tale Sequel Show Approaches Gilead Differently Explained By EPsExclusive: Bruce Miller and Warren Littlefield explain how The Handmaid's Tale's sequel show, The Testaments, approaches ...
3d
US Weekly on MSNWhat to Know About ‘The Handmaid’s Tale’ Spinoff ‘The Testaments’: Returning Cast Members and MoreHulu's spinoff of 'The Handmaid's Tale' titled 'The Testaments' comes after the original show's sixth and final season ...
The Handmaid’s Tale Season 6 finale is just a few weeks away, but fans hoping for a neatly wrapped story to June Osbourne and ...
Wesley Sundquist, a biochemist at University of Utah, and Tomas Cihlar, a virologist at Gilead, a biopharmaceutical company, ...
Wesley Sundquist Named to TIME’s Annual TIME100 List of the 100 Most Influential People in the World
Research in the Sundquist lab laid the foundations for the development of lenacapavir, a drug that prevents HIV infection ...
As the final season of "The Handmaid's Tale" begins today, we're taking a look back on everything to know about the hit Hulu ...
5don MSN
The final season of "The Handmaid's Tale" will have 10 episodes. Here what time and day the next episode will release on Hulu ...
11don MSN
The resistance against Gilead carries on. Here's what you need to remember before "The Handmaid's Tale" Season 6 starts.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results